Quarter
Charts

MiniMed Group, Inc.

MMED

CIK 0002062583 · Quarterly mode · latest period FY2026 (Q4) (ending 2026-01-23) · sourced from SEC EDGAR

At a glance · FY2026 (Q4)

Revenue
$790M
↑+15.0% +$103Mvs FY2025 (Q4)
Gross Profit
$362M
↓-8.4% -$33Mvs FY2025 (Q4)

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$167M
investment in PP&E
Stock-based comp (TTM)
$38M
non-cash dilution

Balance sheet · 2026-01-23

latest filed snapshot
Total assets
$4.34B
everything owned
Total liabilities
$881M
everything owed
Stockholders' equity
$3.46B
shareholder claim

Recent performance · 7 quarters

Revenue↑+15.0% +$103M
$790M
Net Income↓-1090.0% -$109M
$-119M
Free Cash Flow
$-31M
Operating Margin↓-15.7pts
-12.7%

Drill down

MMED Sankey

See MiniMed Group, Inc.'s revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

MMED Charts

7 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

MMED Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics